Skip to main content
SpringerLink
Log in

Stress Related Hair Disorders

  • Chapter
  • First Online:
Stress and Skin Disorders

  • 1403 Accesses

Abstract

For years stress has been suspected as a possible cause of hair loss especially through an impact on hair follicle cycle. Numerous growth factors, cytokines, hormones and neuropeptides involved in a systemic stress response also act directly on hair cycle. Changes of the hair growth cycle therefor result in alopecia. Telogen effluvium and alopecia areata are the most tightly associated with stress due to pathogenesis. However every type of hair loss results in a psychological impact that lowers quality of life and aggravates the stress.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arck PC, Handjiski B, Peters EM, Hagen E, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol. 2003;12(5):580–90.

    Article  CAS  PubMed  Google Scholar 

  2. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28(7):916–31.

    Article  CAS  PubMed  Google Scholar 

  3. Gow R, Thomson S, Rieder M, Van Uum S, Koren G. An assessment of cortisol analysis in hair and its clinical applications. Forensic Sci Int. 2010;196(1–3):32–7.

    Article  CAS  PubMed  Google Scholar 

  4. Karlen J, Ludvigsson J, Frostell A, Theodorsson E, Faresjo T. Cortisol in hair measured in young adults – a biomarker of major life stressors? BMC Clin Pathol. 2011;11:12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2012;8(1):22–32.

    Article  CAS  Google Scholar 

  6. Paus R. Stress and the skin. Exp Dermatol. 2001;10(5):367.

    Article  CAS  PubMed  Google Scholar 

  7. Sehgal VN, Srivastava G, Aggarwal AK, Midha R. Hair biology and its comprehensive sequence in female pattern baldness: treatment modalities – part III. Skinmed. 2013;11(5):287–90.

    PubMed  Google Scholar 

  8. Sehgal VN, Srivastava G, Aggarwal AK, Midha R. Hair biology and its comprehensive sequence in female pattern baldness: diagnosis and treatment modalities – Part I. Skinmed. 2013;11(1):39–45; quiz 45.

    PubMed  Google Scholar 

  9. Ito T. Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci. 2010;60(2):67–73.

    Article  CAS  PubMed  Google Scholar 

  10. Ito N, Sugawara K, Bodo E, Takigawa M, van Beek N, Ito T, Paus R. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol. 2010;130(4):995–1004.

    Article  CAS  PubMed  Google Scholar 

  11. Maurer M, Fischer E, Handjiski B, von Stebut E, Algermissen B, Bavandi A, Paus R. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest. 1997;77(4):319–32.

    CAS  PubMed  Google Scholar 

  12. Goryachkina VL, Ivanova MY, Tsomartova DA, Kartashkina NL, Kuznetsov SL. Regulation of hair follicle cycle. Morfologiia. 2014;146(5):83–7.

    CAS  PubMed  Google Scholar 

  13. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R. Indications for a ‘brain-hair follicle axis (BHA)’: inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J. 2001;15(13):2536–8.

    CAS  PubMed  Google Scholar 

  14. Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, Jiang Y, Shang J, Murao K, Chen JW, Fu WQ, Zhang GX. Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One. 2013;8(4):e61574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wang L, Guo LL, Wang LH, Zhang GX, Shang J, Murao K, Chen DF, Fan XH, Fu WQ. Oxidative stress and substance P mediate psychological stress-induced autophagy and delay of hair growth in mice. Arch Dermatol Res. 2015;307(2):171–81.

    Article  CAS  PubMed  Google Scholar 

  16. Kawana S, Liang Z, Nagano M, Suzuki H. Role of substance P in stress-derived degranulation of dermal mast cells in mice. J Dermatol Sci. 2006;42(1):47–54.

    Article  CAS  PubMed  Google Scholar 

  17. McElwee KJ, Sinclair R. Hair physiology and its disorders. Drug Discovery Today: Disease Mechanisms. 2008;5(2):e163–71.

    Article  Google Scholar 

  18. Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996;14(4):723–31.

    Article  CAS  PubMed  Google Scholar 

  19. Piraccini BM, Iorizzo M, Rech G, Tosti A. Drug-induced hair disorders. Curr Drug Saf. 2006;1(3):301–5.

    Article  CAS  PubMed  Google Scholar 

  20. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–5.

    Article  CAS  PubMed  Google Scholar 

  21. Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: common and uncommon cases. Int J Dermatol. 2007;46 Suppl 1:18–22.

    Article  PubMed  Google Scholar 

  22. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. 1996;35(6):899–906.

    Article  CAS  PubMed  Google Scholar 

  23. Horenstein VD, Williams LE, Brady AR, Abee CR, Horenstein MG. Age-related diffuse chronic telogen effluvium- type alopecia in female squirrel monkeys (Saimiri boliviensis boliviensis). Comp Med. 2005;55(2):169–74.

    PubMed  Google Scholar 

  24. Mirzoyev SA, Schrum AG, Davis MD, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1 % by Rochester Epidemiology Project, 1990–2009. J Invest Dermatol. 2014;134(4):1141–2.

    Article  CAS  PubMed  Google Scholar 

  25. Gulec AT, Tanriverdi N, Duru C, Saray Y, Akcali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol. 2004;43(5):352–6.

    Article  PubMed  Google Scholar 

  26. McDonagh AJ, Messenger AG. The aetiology and pathogenesis of alopecia areata. J Dermatol Sci. 1994;7(Suppl):S125–35.

    Article  PubMed  Google Scholar 

  27. McDonagh AJ, Messenger AG. The pathogenesis of alopecia areata. Dermatol Clin. 1996;14(4):661–70.

    Article  CAS  PubMed  Google Scholar 

  28. de Hollanda TR, Sodre CT, Brasil MA, Ramos ESM. Quality of life in alopecia areata: a case–control study. Int J Trichol. 2014;6(1):8–12.

    Article  Google Scholar 

  29. Witkowski AM, Schwartz RA, Janniger CK. Trichotillomania: an important psychocutaneous disorder. Cutis. 2010;86(1):12–6.

    PubMed  Google Scholar 

  30. Franklin ME, Zagrabbe K, Benavides KL. Trichotillomania and its treatment: a review and recommendations. Expert Rev Neurother. 2011;11(8):1165–74.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Walther MR, Snorrason I, Flessner CA, Franklin ME, Burkel R, Woods DW. The trichotillomania impact project in young children (TIP-YC): clinical characteristics, comorbidity, functional impairment and treatment utilization. Child Psychiatry Hum Dev. 2014;45(1):24–31.

    Article  PubMed  Google Scholar 

  32. Lochner C, Stein DJ, Woods D, Pauls DL, Franklin ME, Loerke EH, Keuthen NJ. The validity of DSM-IV-TR criteria B and C of hair-pulling disorder (trichotillomania): evidence from a clinical study. Psychiatry Res. 2011;189(2):276–80.

    Article  PubMed  Google Scholar 

  33. Stein DJ, Grant JE, Franklin ME, Keuthen N, Lochner C, Singer HS, Woods DW. Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V. Depress Anxiety. 2010;27(6):611–26.

    Article  PubMed  Google Scholar 

  34. Sah DE, Koo J, Price VH. Trichotillomania. Dermatol Ther. 2008;21(1):13–21.

    Article  PubMed  Google Scholar 

  35. Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46(6):807–21; quiz 22–6.

    Article  PubMed  Google Scholar 

  36. Cline BW. Prevention of chemotherapy-induced alopecia: a review of the literature. Cancer Nurs. 1984;7(3):221–8.

    Article  CAS  PubMed  Google Scholar 

  37. Trueb RM. Chemotherapy-induced hair loss. Skin Therapy Lett. 2010;15(7):5–7.

    CAS  PubMed  Google Scholar 

  38. Schilli MB, Paus R, Menrad A. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. J Invest Dermatol. 1998;111(4):598–604.

    Article  CAS  PubMed  Google Scholar 

  39. Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):e37–47.

    Article  PubMed  Google Scholar 

  40. Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011;24(4):432–42.

    Article  PubMed  Google Scholar 

  41. Yun SJ, Kim SJ. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007;215(1):36–40.

    Article  CAS  PubMed  Google Scholar 

  42. Wang J, Lu Z, Au JL. Protection against chemotherapy-induced alopecia. Pharm Res. 2006;23(11):2505–14.

    Article  CAS  PubMed  Google Scholar 

  43. Benjamin B, Ziginskas D, Harman J, Meakin T. Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study. Psychooncology. 2002;11(3):244–8.

    Article  PubMed  Google Scholar 

  44. Pozo-Kaderman C, Kaderman RA, Toonkel R. The psychosocial aspects of breast cancer. Nurse Pract Forum. 1999;10(3):165–74.

    CAS  PubMed  Google Scholar 

  45. McGarvey EL, Baum LD, Pinkerton RC, Rogers LM. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001;9(6):283–9.

    Article  CAS  PubMed  Google Scholar 

  46. Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol. 2001;19(2):211–25.

    Article  CAS  PubMed  Google Scholar 

  47. Ohyama M. Primary cicatricial alopecia: recent advances in understanding and management. J Dermatol. 2012;39(1):18–26.

    Article  CAS  PubMed  Google Scholar 

  48. Dogra S, Sarangal R. What’s new in cicatricial alopecia? Indian J Dermatol Venereol Leprol. 2013;79(5):576–90.

    Article  PubMed  Google Scholar 

  49. Olsen E, Stenn K, Bergfeld W, Cotsarelis G, Price V, Shapiro J, Sinclair R, Solomon A, Sperling L, Whiting D. Update on cicatricial alopecia. J Invest Dermatol Symp Proc/Soc Invest Dermatol, Inc [and] Eur Soc Dermatol Res. 2003;8(1):18–9.

    Article  CAS  Google Scholar 

  50. Van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron. 2004;35(3):193–200.

    Article  PubMed  Google Scholar 

  51. Keogh EV, Walsh RJ. Rate of greying of human hair. Nature. 1965;207(999):877–8.

    Article  CAS  PubMed  Google Scholar 

  52. Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36(1):29–54.

    Article  CAS  PubMed  Google Scholar 

  53. Lerner AB. Gray hair and sympathectomy. Report of a case. Arch Dermatol. 1966;93(2):235–6.

    Article  CAS  PubMed  Google Scholar 

  54. Levine N, Sheftel SN, Eytan T, Dorr RT, Hadley ME, Weinrach JC, Ertl GA, Toth K, McGee DL, Hruby VJ. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA. 1991;266(19):2730–6.

    Article  CAS  PubMed  Google Scholar 

  55. Nordlund JJ. The pigmentary system and inflammation. Pigment Cell Res/sponsored by the Eur Soc Pigment Cell Res Int Pigment Cell Soc. 1992;5(5 Pt 2):362–5.

    Article  CAS  Google Scholar 

  56. Meidan VM, Touitou E. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. Drugs. 2001;61(1):53–69.

    Article  CAS  PubMed  Google Scholar 

  57. Zappacosta AR. Reversal of baldness in patient receiving minoxidil for hypertension. N Engl J Med. 1980;303(25):1480–1.

    CAS  PubMed  Google Scholar 

  58. Sinclair RD. Management of male pattern hair loss. Cutis. 2001;68(1):35–40.

    CAS  PubMed  Google Scholar 

  59. Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990;95(5):553–7.

    Article  CAS  PubMed  Google Scholar 

  60. Kamiya T, Shirai A, Kawashima S, Sato S, Tamaoki T. Hair follicle elongation in organ culture of skin from newborn and adult mice. J Dermatol Sci. 1998;17(1):54–60.

    Article  CAS  PubMed  Google Scholar 

  61. Kubilus J, Kvedar JC, Baden HP. Effect of minoxidil on pre- and postconfluent keratinocytes. J Am Acad Dermatol. 1987;16(3 Pt 2):648–52.

    Article  CAS  PubMed  Google Scholar 

  62. Carpenter JS, Brockopp DY. Evaluation of self-esteem of women with cancer receiving chemotherapy. Oncol Nurs Forum. 1994;21(4):751–7.

    CAS  PubMed  Google Scholar 

  63. Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med. 1999;8(8):1091–5.

    Article  CAS  PubMed  Google Scholar 

  64. Freedman TG. Social and cultural dimensions of hair loss in women treated for breast cancer. Cancer Nurs. 1994;17(4):334–41.

    Article  CAS  PubMed  Google Scholar 

  65. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, Richard MA, Loundou A, Auquier P, Grob JJ. Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol. 2010;130(12):2830–3. Epub 2010/08/20. doi: 10.1038/jid.2010.232. PubMed PMID: 20720568.

  66. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.

    Article  CAS  PubMed  Google Scholar 

  67. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol. 1997;136(2):202–6.

    Article  CAS  PubMed  Google Scholar 

  68. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37(1):41–50.

    Article  CAS  PubMed  Google Scholar 

  69. Fabbrocini G, Panariello L, De Vita V, Vincenzi C, Lauro C, Nappo D, Ayala F, Tosti A. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol. 2013;27(3):e276–81.

    Article  CAS  PubMed  Google Scholar 

  70. Sehgal VN, Kak R, Aggarwal A, Srivastava G, Rajput P. Male pattern androgenetic alopecia in an Indian context: a perspective study. J Eur Acad Dermatol Venereol: JEADV. 2007;21(4):473–9.

    Article  CAS  PubMed  Google Scholar 

  71. Katoulis AC, Christodoulou C, Liakou AI, Kouris A, Korkoliakou P, Kaloudi E, Kanelleas A, Papageorgiou C, Rigopoulos D. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges. 2015;13(2):137–42.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Medical University of Warsaw, Warszawa, Poland

    Anna Skrok MD & Lidia Rudnicka MD, Phd

Authors
  1. Anna Skrok MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lidia Rudnicka MD, Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lidia Rudnicka MD, Phd .

Editor information

Editors and Affiliations

  1. Centro Studi per la Ricerca Multidisciplinare e Rigenerativa Department of Dermatology, Università degli Studi Guglielmo Marconi, Rome, Italy

    Katlein França

  2. Department of Psychiatry, Central Michigan University College of Medicine, Saginaw, Michigan, USA

    Mohammad Jafferany

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Skrok, A., Rudnicka, L. (2017). Stress Related Hair Disorders. In: França, K., Jafferany, M. (eds) Stress and Skin Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-46352-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46352-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46351-3

  • Online ISBN: 978-3-319-46352-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation